Cargando…
Brief review: cell replacement therapies to treat type 1 diabetes mellitus
Human embryonic stem cells (hESCs) and induced pluripotent cells (iPSCs) have the potential to differentiate into any somatic cell, making them ideal candidates for cell replacement therapies to treat a number of human diseases and regenerate damaged or non-functional tissues and organs. Key to the...
Autores principales: | Hayek, Alberto, King, Charles C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471705/ https://www.ncbi.nlm.nih.gov/pubmed/28702240 http://dx.doi.org/10.1186/s40842-016-0023-y |
Ejemplares similares
-
Insulin Edema in Type 1 Diabetes Mellitus: Report of a Case and Brief Review of the Literature
por: Derya Bulus, Ayse, et al.
Publicado: (2016) -
Type 2 diabetes mellitus, cognition and brain in aging: A brief review
por: Kumar, Rajeev, et al.
Publicado: (2009) -
Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
por: Wan, Xin-Xing, et al.
Publicado: (2022) -
Consequences of Type 1 and 2 Diabetes Mellitus on the Cardiovascular Regulation During Exercise: A Brief Review
por: Roberto, Silvana, et al.
Publicado: (2017) -
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
por: Jahansouz, Cyrus, et al.
Publicado: (2011)